Peripheral Neuropathy Trial, Recruiting (NCT05295498)

Peripheral Neuropathy Trial, Recruiting NCT05295498 Sponsor: Jakub Antczak Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT05295498 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with peripheral neuropathy (nerve damage in the limbs or body)
People who have had nerve pain that has stayed at a constant level for at least one month and who need pain relief medication more than once a week
People whose pain scores at least 30 out of 100 on a pain rating scale at the time of joining the trial

Who may not be able to join:

People who have severe depression
People who have personality disorders or other mental health conditions that could interfere with taking part in the study
People who have thinking or memory difficulties that could interfere with taking part in the study
People who have epilepsy
People who have any magnetic metal material in their body within range of a magnetic field
People who are pregnant
People who are likely to become pregnant
People who have electrodes implanted inside their skull

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tomasz Klupa, Professor, Jagiellonian University

Phone: +48 795 421 153

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05295498

Sponsor: Jakub Antczak

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +48 795 421 153

More information: https://clinicaltrials.gov/study/NCT05295498

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with peripheral neuropathy (nerve damage in the limbs or body)
People who have had nerve pain that has stayed at a constant level for at least one month and who need pain relief medication more than once a week
People whose pain scores at least 30 out of 100 on a pain rating scale at the time of joining the trial

Who may not be able to join:

People who have severe depression
People who have personality disorders or other mental health conditions that could interfere with taking part in the study
People who have thinking or memory difficulties that could interfere with taking part in the study
People who have epilepsy
People who have any magnetic metal material in their body within range of a magnetic field
People who are pregnant
People who are likely to become pregnant
People who have electrodes implanted inside their skull

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jakub Antczak

Registry

ClinicalTrials.gov

Start date

4 November 2022

Est. completion

31 March 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Visual Analogue Scale of Pain Severity after rTMS; Visual Analogue Scale of Pain Severity First Follow-up; Visual Analogue Scale of Pain Severity Second Follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov